Authors: Davies, A Vannais, D Fernie, BA Wilson, AB Gustafson, D Willers, C Waldren, C

Citation: A. Davies et al., An aberrant form of CD59 derived from HeLa cells, EXP CLIN IM, 18(2), 2001, pp. 71-79

Authors: Margos, G Navarette, S Butcher, G Davies, A Willers, C Sinden, RE Lachmann, PJ

Citation: G. Margos et al., Interaction between host complement and mosquito-midgut-stage Plasmodium berghei, INFEC IMMUN, 69(8), 2001, pp. 5064-5071

Authors: Fernie-King, BA Seilly, DJ Willers, C Wurzner, R Davies, A Lachmann, PJ

Citation: Ba. Fernie-king et al., Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes, IMMUNOLOGY, 103(3), 2001, pp. 390-398

Authors: Hillen, U Willers, C Goos, M

Citation: U. Hillen et al., Melanoma erysipeloides: successful treatment by chemoimmunotherapy, BR J DERM, 143(4), 2000, pp. 904-906

Authors: Stadler, R Otte, HG Henz, BM Kuhl, P Zwingers, T Willers, C Sterry, W

Citation: R. Stadler et al., Prospective randomized multicenter clinical trial on the use of interferonalpha-2a plus acitretin versus interferon alpha-2a plus PUVA in patients with cutaneous T-cell lymphoma (CTCL) stages I and II (vol 92, pg 2578, 1998), BLOOD, 93(8), 1999, pp. 2753-2753